These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


49 related items for PubMed ID: 6743867

  • 1. Echocardiographic aspects of pulmonary arterial hypertension in chronic lung disease.
    Morpurgo M, Saviotti M, Dickelé MC, Casazza F, Torbicki J, Weitzenblum E, Zielinski J.
    Bull Eur Physiopathol Respir; 1984; 20(3):251-5. PubMed ID: 6743867
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Haemodynamic correlation with lung biopsy findings in isolated ventricular septal defect with or without pulmonary hypertension.
    Zakaria M.
    Hokkaido Igaku Zasshi; 1997 Nov; 72(6):607-19. PubMed ID: 9465314
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognosis of pulmonary hypertension in chronic obstructive pulmonary disease.
    Weitzenblum E.
    Cor Vasa; 1980 Nov; 22(6):418-27. PubMed ID: 7471756
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease.
    Madden BP, Allenby M, Loke TK, Sheth A.
    Vascul Pharmacol; 2006 May; 44(5):372-6. PubMed ID: 16574495
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D, Mouthon L, Hachulla E, Pagnoux C, de Groote P, Remy-Jardin M, Matran R, Lambert M, Queyrel V, Morell-Dubois S, Guillevin L, Hatron PY.
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Follow-up in patients with chronic obstructive lung diseases with special reference to the pressure behavior in the pulmonary artery].
    Kirsten D, Meister W, Vattrodt W, Pielesch W, Seelig U, Hofmann I, Mönch D.
    Z Erkr Atmungsorgane; 1987 May; 169(2):109-16. PubMed ID: 3687102
    [Abstract] [Full Text] [Related]

  • 17. Measurement of human pulmonary arterial volume in vivo.
    Lewis ML, Herrera CE.
    Bull Eur Physiopathol Respir; 1979 May; 15(5):925-34. PubMed ID: 508985
    [Abstract] [Full Text] [Related]

  • 18. [Prediction of pulmonary hypertension from simple, noninvasive parameters using discriminant analysis].
    Evers H, Liehs F.
    Z Erkr Atmungsorgane; 1985 May; 164(3):284-7. PubMed ID: 4013407
    [Abstract] [Full Text] [Related]

  • 19. Can pulmonary hypertension be predicted by non-invasive approach? Echocardiographic and haemodynamic study.
    Bertoli L, Rizzato G, Merlini R, Lo Cicero S, Mandelli V, Gallico S, Pezzano A.
    Acta Cardiol; 1984 May; 39(2):97-106. PubMed ID: 6610273
    [Abstract] [Full Text] [Related]

  • 20. Evaluation problems of a long-term study on evolving pulmonary arterial hypertension in chronic non specific lung disease.
    Naszlady A, Rodek I.
    G Ital Cardiol; 1984 May; 14 Suppl 1():49-55. PubMed ID: 6534767
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.